Current Month

Click on the Newsletter and read!

New impact factor is released: 4.437


  • Comparison of cognitive impairment in Darier disease and Hailey-Hailey disease
    Philip Curman, Johanna Bern, Linnea Sand, Martin Cederlöf, Etty Bachar-Wikstrom, Jakob D. Wikström
  • Patients’ perception of vitiligo severity
    Nanja van Geel, Charlotte Moock, Marloes Zuidgeest, Sanne Elisabeth Uitentuis, Albert Wolkerstorfer, Reinhart Speeckaert
  • Patient and tumour characteristics of keratoacanthoma
    Agnes Kolmodin, Nirmala P. Pandeya, Catherine M. Olsen, Jean Claude Dusingize, David C. Whiteman, Magdalena Claeson
  • Visual impact of giant congenital melanocytic naevi
    Francesca Sampogna, Melinda González, Mirella Pascini-Garrigós, Neus Calbet-Llopart, Jennifer L. Hay, et al.
  • Locoregional treatments for digital ulcers
    Ingrid Costedoat, Maeva Masson, Thomas Barnetche, Pierre Duffau, Estibaliz Lazaro, Christophe Richez, et al.
  • Transient increase in circulating basophils and eosinophils in dupilumab-associated conjunctivitis in patients with atopic dermatitis
    Michie Katsuta, Yozo Ishiuji, Hiroyuki Matsuzaki, Ken-ichi Yasuda, Budiman Kharma, Yoshimasa Nobeyama, et al.
  • Quiz

    QUIZ - 2021-07-07
    Multiple Firm Livid Nodules on the Proximal Lower Leg: A Quiz
    Kai-Philipp Linse, Christine Fink, Ferdinand Toberer
    Show more quizzes »

    This is ActaDV

    An international peer-reviewed journal for clinical and experimental research in the field of dermatology and venereology.

    Published by the Non-Profit Organization Society for Publication of Acta Dermato-Venereologica

    The official Journal of:
    European Society for Dermatology and Psychiatry

    Affiliated with:
    International Forum for the Study of Itch

    Go to Content »

    ISI Impact Factor 2020: 4.437 H Index: 83

    SCImago Journal & Country Rank
    Sign up for e-mail alerts and be notified when the next Newsletter (summing up previous month' published articles) is released.

    By sending this form you confirm that your personal data will be stored with regards to the privacy policy.

    From current month: 6 (101)

    Choice of Systemic Drugs for the Management of Moderate-to-severe Psoriasis: A Cross-country Comparison Based on National Health Insurance Data
    Emilie Sbidian, Myriam Mezzarobba, Jason Shourick, Cécile Billionnet, Joël Coste, Alain Weill, Jérémie Rudant, Olivier Chosidow, Loes Hollestein, Tamar Nijsten
    Current management of moderate-to-severe psoriasis may be heterogeneous between European countries, probably due to differences in the organization of care. The aim of this study was to compare the utilization of systemic treatments for psoriasis between 2 coun­tries. All adults with psoriasis who were registered in the French (SNDS) and the Dutch (VEKTIS) national health insurance databases between 2012 and 2016 were eligible for inclusion. In France, 105,035 (15%) of 684,156 patients and, in the Netherlands, 37,405 (28.6%) of 130,822 patients received at least a systemic agent. In France, the proportion of patients treated with systemic agents was constant, while the type of drugs dispensed shifted from non-biological to biological agents. In the Netherlands, the first systemic treatment was methotrexate and, in France, acitretin. In France, the choice of the first biologic was much more variable than it was in the Netherlands, where a large proportion of patients were dispensed ustekinumab. This study highlights discrepancies between France and the Netherlands concerning the choice of first non-biologic agent and first biologic agent for patients with psoriasis. These discrepancies may be due to differences in the healthcare systems between the 2 countries.
    Pages: 1-6
    Volume 93, Issue 3
    Skin pH: From Basic SciencE to Basic Skin Care
    Saba M. Ali, Gil Yosipovitch
    Volume 95, Issue 1
    Evidence-based Danish Guidelines for the Treatment of Malassezia-related Skin Diseases
    Marianne Hald, Maiken C. Arendrup, Else L. Svejgaard, Rune Lindskov, Erik K. Foged, Ditte Marie L. Saunte
    Volume 96, Issue 1
    Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria
    Marina Abajian, Laia Curto-Barredo, Karoline Krause, Eva Santamaria, Iñaki Izquierdo, Martin K. Church, Marcus Maurer, Ana Giménez-Arnau
    Cutaneous Expression of Familial Cancer Syndromes
    Anne-Johanne Andersen, Juliane Schierbeck, Anette Bygum, Nieves Puente-Pablo
    Association of Actinic Keratosis with Rheumatoid Arthritis and Psoriasis: A Nationwide Population-Based Study in Korea
    Hyun Jee Kim, Yeong Ho Kim, So Yeon Yun, Dong Soo Yu, Young Bok Lee
    Seven- and 23-year-old Siblings with Papulonodular Lesions after Sun Exposure: A Quiz
    Davide Neri, Karola Maria Stieler, Annika Vogt, Kamran Ghoreschi, Ulrike Blume-Peytavi
    Burden of Itch in Patients with Basal Cell Carcinoma
    Iwona Chlebicka, Aleksandra A. Stefaniak, Łukasz Matusiak, Jacek C. Szepietowski
    Characterization of the Oral and Gut Microbiota in Patients with Psoriatic Diseases: A Systematic Review
    Tanja Todberg, Hannah Kaiser, Claus Zachariae, Alexander Egeberg, Anne-Sofie Halling, Lone Skov